Skip to content
Mesothelioma.net
phone iconCall1-800-692-8608 chat icon Chat 24/7 Live Chat
Menu
  • Malignant Mesothelioma
    • About Mesothelioma
      • How to Survive Mesothelioma
      • 100 Questions & Answers about Mesothelioma (Free Book)
      • Symptoms
      • Diagnosis
      • Prognosis
      • Life Expectancy
    • Types
      • Pleural
      • Peritoneal
      • Epithelioid
      • Sarcomatoid
      • Biphasic
    • Stages
      • Stage 1
      • Stage 2
      • Stage 3
      • Stage 4
    • Additional Information
      • Causes
      • Asbestos and Its Dangers
      • Facts
      • Support
      • Financial Compensation
      • FREE Mesothelioma Packet
  • Treatment
    • Treatment Options
      • Surgery
      • Chemotherapy
      • Radiation Therapy
      • Multimodal Therapy
      • Medications
      • Palliative Treatment
    • Find Top Doctors
      • Doctors
      • Treatment Centers
      • Treatment & Doctors Near You
      • New Treatments
      • Care Providers
      • Clinical Trials
      • Costs
  • Asbestos Trusts
  • Compensation
  • Veteran Assistance
    • Mesothelioma and Veterans
      • VA Claims for Mesothelioma
      • Vietnam Veterans
    • Military Branches and Asbestos
      • Navy Veterans
      • Navy Ships
      • Marine Corps Veterans
      • Army Veterans
      • Air Force Veterans
      • U.S. Coast Guard
  • Surviving Mesothelioma
  • About Us / Contact
  • Home
  • ›
  • Malignant Mesothelioma
  • ›
  • Diagnosis
  • ›
  • Pathology
Page Updated: June 28, 2022

Mesothelioma Pathology

Anne Courtney Page Medically Reviewed and Edited by Anne Courtney, AOCNP, DNP

FREE Mesothelioma Packet

Fact Checked

This page has been fact-checked by a Doctor of nursing practice specializing in Oncology and has experience working with mesothelioma patients.

FREE Mesothelioma Packet

Sources of information are listed at the bottom of the article. We make every attempt to keep our information accurate and up-to-date. 

Please Contact Us with any questions or comments.

Pathology is the study of a disease, including a description of its characteristics and how it progresses. Pathologists examine cells from biopsies to identify cancerous cells, types of cancer, and the stage. Mesothelioma pathology provides a complete picture of the cancer, contributing to a more accurate diagnosis and an informed treatment plan.

FREE Mesothelioma Packet

Asbestos – The Cause of Mesothelioma

The primary cause of mesothelioma is past exposure to asbestos. Most people exposed encountered it on the job. Many workers inhaled tiny fibers of asbestos, which then caused inflammation and damage in mesothelial tissue.

In some people, this damage leads to the development of cancerous cells. It can cause lung cancer, pleural or peritoneal mesothelioma, and in some cases, other types of cancer.

How Pathology Is Used to Diagnose Mesothelioma

Pathology is an essential part of diagnosing mesothelioma. There is no single test or blood marker that determines if a person has mesothelioma. Physicians look at symptoms and medical history to make a diagnosis, but they also rely on pathologists.

Pathologists are like detectives who look at the evidence from a patient to draw several conclusions:

  • If the patient has tumors or other abnormal growths
  • If those growths are malignant (cancerous) or benign
  • The type of cancer
  • The type of cell
  • Where the cancer has spread

One of the most important roles of pathology in mesothelioma diagnoses is distinguishing the cancer from other types. Mesothelioma is rare, and doctors often mistake it for other, more common cancers with similar characteristics.

For instance, it is easy to confuse mesothelioma and adenocarcinoma. The latter is a cancer of the glands inside organs. Adenocarcinoma of the lung is the most common type of lung cancer, so mesothelioma is often misdiagnosed as this disease.

The two types of cancer cause similar symptoms and have similar features on imaging scans. Pathologists play an essential role in distinguishing between these cancers by examining the cells.

Because they are not the same type of cancer, treatment differs for adenocarcinoma and mesothelioma. Getting the right diagnosis is essential for the patient’s outcome.

The Pathology of Tumor Growth

One way of diagnosing mesothelioma is to observe the anatomy of a particular cancer or how the tumors grow and develop. The most apparent anatomical sign of mesothelioma is the thickening of the pleural space, the lining of the lungs.

The tumor may also develop small nodules over the surface of the pleura and other similar areas, including the diaphragm.

Pathologists have described rare cases of localized malignant mesothelioma. This presents as a single mass rather than the characteristic pleural thickening and nodules.

The common nodules characteristic of mesothelioma usually range in size from one millimeter to one centimeter. As the cancer advances, the nodules and tumors form plaques. Plaques develop into thick tissue that encases and interferes with organs, usually the lungs.

Metastasis, or the spread of cancer cells from the primary location, is another sign of advanced mesothelioma. With pleural mesothelioma, cancer often spreads to skeletal muscle in the chest cavity.

It can also spread to deep layers of the skin, the diaphragm, organs of the abdominal cavity, and the lymph nodes. The tumor often spreads to the liver, spleen, intestines, and other abdominal organs in peritoneal mesothelioma.

Histology: Describing Mesothelioma Cells

Mesothelioma is difficult to diagnose by examining the macrostructure of the tumor in imaging scans. Pathologists examine microscopic structures like cells.

Pathologists need a biopsy for a complete and accurate diagnosis. This involves extracting cells from the tumor and examining them under a microscope for characteristic signs of mesothelioma.

Pathologists use specific stains to identify chemicals and structures within and on the surfaces of cancer cells from the biopsy sample. Two main cell types may be found in tissue from a mesothelioma tumor:[1]

  • Epithelioid. Cells may be cube, oval, or polygonal and mimic non-cancerous cells of the mesothelium. The epithelioid type accounts for most cases of mesothelioma and has the best prognosis.
  • Sarcomatoid. These cells are shaped like spindles that mimic those in lung cancer. This is yet another reason mesothelioma is difficult to diagnose.
  • Biphasic. In biphasic mesothelioma tumors, there are both epithelioid and sarcomatoid cells.

These are the most common cell types in mesothelioma, but there are also rare types: deciduoid, cystic, papillary, desmoplastic, lymphohistiocytoid, and heterologous.

Identifying cell type is an important part of the pathology of this disease because it informs treatment. Some of the rare types may be benign. Sarcomatoid mesothelioma spreads particularly fast and requires the most aggressive treatments.

Cytology

Histology is the identification of cell type, but pathologists often dive deeper. They use cytology to study additional characteristics of the cancer cells, including interior structures and genes.

Pathologists identifying mesothelioma cells often look for the BAP 1 gene, for instance. It is a tumor-suppressing gene that is often missing in patients with malignant mesothelioma.[2]

Pathologists also look for pleomorphism, a variety of shapes and sizes in the nuclei of the cells. Mesothelioma cells might contain calcifications called psammoma bodies, which pathologists can identify.[2]

Immunohistochemistry

Pathologists can also use immunohistochemistry to identify cancer cells of the mesothelium. This is one of the most accurate ways to distinguish between mesothelium cancer cells and other types of cancers.

Immunohistochemistry uses antibodies to detect the antigens that are characteristic of a particular type of cancer cell.[3]

To see the antibodies, samples are typically stained or attached to a fluorescent dye. As the antibodies bind to antigens specific to mesothelioma, they become visible under these conditions.

If they do not attach, the stain or dye is not activated, and the presence of mesothelioma is not confirmed.[3] Some of the most important markers pathologists look for to confirm a mesothelioma diagnosis include:

  • Keratin
  • Calretinin
  • Cytokeratin 5
  • Cytokeratin 5/6
  • WT-1
  • Podoplanin (D2-40)

Pathologists also look for the absence of certain markers to rule out other cancers and confirm mesothelioma.

An immunohistochemistry test is often required in legal cases of asbestos-related mesothelioma to confirm the diagnosis. It is one of the most important pieces of the diagnostic puzzle.

Updates to Mesothelioma Pathology

The International Mesothelioma Group details guidelines for the pathologic diagnosis of mesothelioma. Experts in the field update these guidelines regularly. They published the most recent updates in 2020. These are some of the updates or changes:[4]

  • Using multiple markers to distinguish between malignant and benign tumors
  • Increased emphasis on nuclear grading to provide patients with a more accurate prognosis
  • Additional features described in epithelioid cells to improve prognosis accuracy
  • Expanded definition of biphasic mesothelioma
  • Assigning transitional features in cells (stretching of the cells) to the sarcomatoid type
  • Adding HEG1 as an important marker for mesothelioma

For someone with mesothelioma, pathology techniques help make more accurate diagnoses. This cancer is already tricky to pinpoint, so detailed pathology helps make early and accurate diagnoses, critical for effective treatment.

Get Your FREE Mesothelioma Packet

Page Medically Reviewed and Edited by Anne Courtney, AOCNP, DNP

Anne Courtney

Anne Courtney has a Doctor of Nursing Practice degree and is an Advanced Oncology Certified Nurse Practitioner. She has years of oncology experience working with patients with malignant mesothelioma, as well as other types of cancer. Dr. Courtney currently works at University of Texas LIVESTRONG Cancer Institutes.

Connect with Doctor of Nursing Practice Anne Courtney
References
  1. Husain, A.N., et al. (2018). Guidelines for Pathologic Diagnosis of Malignant Mesothelioma. Am. Pathol. Lab. Med. 142, 89-108.
    Retrieved from: https://www.archivesofpathology.org/doi/pdf/10.5858/arpa.2017-0124-RA
  2. Roden, A.C. (2021, March 8). Pleural and Peritoneum. Pleural Mesothelial Tumors. Pathology Outlines.
    Retrieved from: https://www.pathologyoutlines.com/topic/pleuramesothelioma.html
  3. Inai, K. (2008, March). Pathology of Mesothelioma. Environ. Health Prev. Med. 13(2), 60-4.
    Retrieved from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2698271/
  4. Schulte, J.J. and Husain, A.N. (2020, June). Update on the Pathologic Diagnosis of Maligmant Mesothelioma. Translational Lung Cancer Research. 9(3), 917-23.
    Retrieved from: https://tlcr.amegroups.com/article/view/39107/pdf
View All References

Site Navigation

Home
Malignant Mesothelioma
How to Survive Mesothelioma
100 Questions & Answers about Mesothelioma (Free Book)
Surviving Mesothelioma - Beating the Odds (Free Book)
FREE Mesothelioma Packet
Symptoms
Shortness of Breath
Cough
Night Sweats and Fever
Weight Loss
Pain
Difficulty Swallowing
Fatigue and Muscle Weakness
Gastrointestinal Complications
Diagnosis
Pathology
Staging
Stage 1
Stage 2
Stage 3
Stage 4
Metastasis and Progression
Brain Metastasis
Biopsy
miRview Test
Imaging
Fine Needle Aspiration Biopsy in Mesothelioma
Biomarkers and Blood Tests
Calretinin
Prognosis
Remission
Recurrence
Death Rate
Life Expectancy
Search for a Mesothelioma Cure
Types
Pleural
Peritoneal
Epithelioid
Sarcomatoid
Biphasic
Pericardial
Testicular
Cell Types
Rare Subtypes of Mesothelioma
Deciduoid
Desmoplastic
Heterologous
Lymphohistiocytoid
Well-Differentiated Papillary
Tubulopapillary
Small Cell
Benign
Adenomatoid
Cystic
Unresectable
Localized
Idiopathic
Omental
Causes
Risk Factors
Latest Research
Genetic Components
Incidence
Latency Period
Mesothelioma Tumor
Health Insurance Coverage
Related Conditions
Immunodeficiency Disorders
Cholangiocarcinoma
Atelectasis
Pleural Plaques
Pleural Thickening
Pleural Effusion
Peritoneal Effusion (Ascites)
Mesothelial Hyperplasia and Proliferation
Pleuritis and Pleurisy
COPD
Anemia
Breast Cancer
Prevention
Complications
Misdiagnosis
Mesothelioma Commercial
Talcum Baby Powder
Lawyer
Lawsuits
Class Action Lawsuits
Settlements
Simian Virus 40
Differences From Other Cancers
Lung Cancer
Women
Children and Young Adults
Unknown Asbestos Exposure
Mesothelioma Without Asbestos
Cause of Death
Facts 
History
Awareness
Government and Research
National Mesothelioma Virtual Bank
Support
What to Expect
Living with Mesothelioma
Help a Loved One
Wrong and Right Things to Say
Caregivers
Financial Tips
Faith
Nutrition and Lifestyle
Intimacy
Mesothelioma and Fertility in Men
Fertility in Women with Mesothelioma
Emotional Health
COVID-19
Assisted Living
Hospice Care
Dying from Mesothelioma
Mourning
Coping Guide for Children
End-of-Life Decisions
Mesothelioma Awareness Day
Compensation for Victims
Lawyer
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington D.C.
Washington
West Virginia
Wisconsin
Wyoming
Lawsuit
Settlements
Statute of Limitations
Treatment
Surgery
Side Effects
Pneumonectomy
Extrapleural Pneumonectomy
Lobectomy
Pleurectomy/Decortication
Post Op Care
Pleurectomy/Decortication vs. Extrapleural Pneumonectomy
Peritonectomy/Cytoreductive Surgery
Thoracotomy
Thoracoscopy
Pericardiectomy
Wedge Resection
Pleurodesis
Pericardiocentesis
Prosthetics
Paracentesis
Thoracentesis
Chemotherapy
Side Effects
Heated Intraperitoneal
Radiation Therapy
Side Effects
Intensity-Modulated
Brachytherapy
Proton Therapy
Image-Guided
External Beam
Three-Dimensional
Multimodal Therapy
New Treatments
SMART Protocol
Gene Therapy
Suicide Gene Therapy
Tumor-Based p53 Therapy
Cryotherapy for Mesothelioma
Tumor Treating Fields
MicroRNA
Palliative Treatment
Osteopathic
Doctors
Treatment Centers
Treatment & Doctors Near You
Mesothelioma Experts
Medications
Alimta (pemetrexed)
Adriamycin (doxorubicin)
Avastin (bevacizumab)
Cytoxan (cyclophosphamide)
Gemzar (gemcitabine)
Keytruda (Pembrolizumab)
Mitomycin
Navelbine (vinorelbine)
Opdivo (nivolumab) and Yervoy (ipilimumab)
Paraplatin (carboplatin)
Platinol (cisplatin)
Rheumatrex (methotrexate)
Sutent (sunitinib)
Taxol (paclitaxel)
Medical Marijuana
Care Providers
Clinical Trials
Anetumab Ravtansine
Atezolizumab
Chimeric Antigen Receptor (CAR) T-Cell
Durvalumab
Immunotoxin
Interferon Alfa-2b
Onconase (Ranpirnase)
VISTA Protein
Costs
Immunotherapy
Nanotechnology
Hyperbaric Oxygen Therapy
Home Medical Equipment
HMGB1 Secretion
Photodynamic Therapy
Targeted Therapies
Apoptosis
Stem Cells
Lung Transplantation
Body-Based Therapies
Alternative Therapies
Paul Kraus’s Method
Doctors and Treatment in Canada
Asbestos Trusts
Veterans
VA Claims for Mesothelioma
Vietnam Veterans
Military Branches and Asbestos
Navy Veterans
Navy Ships
Aircraft Carriers
Battleships
Destroyers
Asbestos on Navy Cruisers
Submarines
Amphibious Ships
Minesweepers
Auxiliary Ships
Marine Corps Veterans
Army Veterans
Air Force Veterans
U.S. Coast Guard
Asbestos
Occupational Exposure
Construction Workers
Shipyard Workers
Ship Repair
Steel Mill Workers
Industrial Workers
Boiler Workers
Power Plant Workers
Firefighters
Automotive Workers
Roofers
Oil Refineries
Mining
Transportation Industry
Machine Operators
Farmers and Agricultural Workers
Migrant Workers
Electrical Wiring
Labor Unions
Prisons
Chimneys, Furnaces, and Wood Stoves
Fiberglass Connection to Mesothelioma
Home Remodeling
School Buildings, Teachers
For Tech Students
Cancer
Lung Cancer
Pleural Based Cancers
Ovarian Cancer
Ovarian Cancer Lawsuits
Companies That Used Asbestos
Awareness and Education
Types of Asbestos & Mesothelioma Risk
Asbestosis
Interstitial Lung Disease
Smoking
Asbestos Ingestion
Exposure in a Natural Disaster
Ban Asbestos
Libby, Montana
Recycling Asbestos
Asbestos Detection
Legal Information by State
Canada
Mexico
United Kingdom
Australia
  • Malignant Mesothelioma
    • Treatment
    • Asbestos Trusts
  • Compensation
    • Veteran Assistance
    • Surviving Mesothelioma
  • FREE Mesothelioma Packet
    • Mesothelioma News
    • About Us / Contact
  • Privacy Policy
    • Disclaimer
    • Editorial Guidelines and Standards
This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information: verify here.
The information provided by Mesothelioma.net is not a substitute for professional medical advice, diagnosis or treatment.

Mesothelioma.net

5430 LBJ Freeway Suite 1200
Dallas, Texas 75240

Serving mesothelioma victims nationwide

1-800-692-8608

  • facebook
  • twitter
© 2022 Mesothelioma.net